Last Price
12.30
Today's Change
+0.11 (0.90%)
Day's Change
11.99 - 12.42
Trading Volume
4,988,736
Exchange: NASDAQ Global Market NASDAQ Global Market
Currency: USD USD
Sector: Healthcare - Healthcare Healthcare - Healthcare
CEO: Mr. Matthew Gline Mr. Matthew Gline
Full Time Employees: 908 908
IPO Date: 2020-12-08 2020-12-08
CIK: 0001635088 0001635088
ISIN: BMG762791017 BMG762791017
CUSIP: G76279101 G76279101
Beta: 1.25 1.25
Last Dividend: 0.00 0.00
Dcf Diff: 14.37 14.37
Dcf: -2.07 -2.07
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, warm autoimmune hemolytic anemia, thyroid eye diseases, sarcoidosis, and staph aureus bacteremia. The company was founded in 2014 and is based in London, the United Kingdom.